Breaking News
Investing Pro 0
Cyber Monday Extended SALE: Up to 60% OFF InvestingPro+ CLAIM OFFER
Close

Abbott Laboratories (0Q15)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
104.5350 0.0000    0.00%
29/11 - Real-time Data. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United Kingdom
ISIN:  US0028241000 
SEDOL:  BYMPY19
  • Volume: 0
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 104.5350 - 104.5350
Abbott Labs 104.5350 0.0000 0.00%

Abbott Laboratories Company Profile

 
Get an in-depth profile of Abbott Laboratories, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealth Care Equipment & Supplies
SectorHealthcare
Employees

113000

Equity Type

ORD

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Contact Information

Top Executives

Name Age Since Title
Robert B. Ford 47 2008 Chairman of the Board, President & CEO
Michelle A. Kumbier 54 2018 Independent Director
Patricia P. Gonzalez 50 2021 Independent Director
Michael F. Roman 62 2021 Independent Director
John G. Stratton 60 2017 Independent Director
William A. Osborn 75 2008 Lead Independent Director
Nancy McKinstry 63 2011 Independent Director
Darren Wayne McDew 61 2019 Independent Director
Glenn F. Tilton 74 2007 Independent Director
Robert J. Alpern 71 2008 Independent Director
Daniel J. Starks 67 2017 Independent Director
Sally E. Blount 60 2011 Independent Director
Claire L. Babineaux-Fontenot 58 2022 Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ABT Comments

Write your thoughts about Abbott Laboratories
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Jonah Garber
Jonah Garber Aug 08, 2022 1:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Abbott and WeightWatchers Partner to Support People Living with Diabetes in Attaining their Health Goals
wayne lim
wayne lim Aug 07, 2022 9:19AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
super boom
wayne lim
wayne lim Aug 07, 2022 9:19AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
super boom
sean delaney
sean delaney Sep 09, 2021 5:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Boom!!
John Cerniuk
John Cerniuk Jul 21, 2021 6:47PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
its coiled like a snake it's ready to spring
Mahdi Hatami
Mahdi Hatami Jun 15, 2021 10:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
best time to buy ABT!
Hassan Abuhassan
Hassan Abuhassan Jun 01, 2021 4:05PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any idea what is the bottom?
mario cruz
mario cruz Jun 01, 2021 4:05PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
106 but this is long term
Hassan Abuhassan
Hassan Abuhassan Jun 01, 2021 4:05PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Thank you.. Hope it will holds and does not drop below $100
mario cruz
mario cruz Jun 01, 2021 2:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
excellent time to buy!!! good company and long run
Rudy Cardenas
Rudy Cardenas Jun 01, 2021 12:56PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It is time to buy! This is extra money, new business created by Covid. Icing on the cake.
Bart Van Der Zanden
Bart Van Der Zanden May 06, 2021 3:37PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy now! i think?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email